Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense, Income Tax (Expense) Benefit and Assets by Segment (Detail)

v3.19.3.a.u2
Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense, Income Tax (Expense) Benefit and Assets by Segment (Detail) - USD ($)
 12 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Segment Reporting Information [Line Items]    
Total net revenue $ 31,816,571 $ 29,218,490
Total cost of sales 10,036,175 8,539,662
Total operating profit 5,062,706 5,189,303
Total depreciation and amortization 206,238 180,264
Total interest expense 1,703,446 1,546,900
Total income tax (expense) benefit (1,100,641) (4,472,504)
Total other comprehensive income (loss) 0 300,119
Total assets 42,886,160 42,390,143
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 30,991,972 28,817,872
Total cost of sales 8,490,824 7,744,208
Total operating profit 8,152,475 5,620,394
Total interest expense 1,703,446 1,546,900
Total income tax (expense) benefit (1,100,641) (4,472,504)
Total other comprehensive income (loss) 0 300,119
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 172,395 104,323
Total cost of sales 249,487 169,397
Total operating profit (113,346) (101,329)
Total interest expense 0  
Total income tax (expense) benefit 0  
Total other comprehensive income (loss) 0  
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 652,204 296,295
Total cost of sales 1,295,864 626,057
Total operating profit (2,976,423) (329,762)
Total interest expense 0  
Total income tax (expense) benefit 0  
Total other comprehensive income (loss) 0  
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 401,311 317,326
Operating Segments [Member] | Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 365,057 281,072
Operating Segments [Member] | PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 36,254 36,254
Operating Segments [Member] | Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 0  
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total assets 28,975,002 26,239,260
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total assets 289,804 319,802
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total assets $ 13,621,354 $ 15,831,081